Other
Valve Replacement Surgery
2
Pipeline Programs↗
1
Active Trials↗
1
Companies Involved↗
Valve Replacement Surgery is an early-stage landscape with 2 programs across 1 company. The most active players are Bayer. 2 therapies are approved.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved2
Analysis
Trial Status
5
clinical trials
Unknown status2 · 40%
Completed2 · 40%
Recruiting1 · 20%
Clinical Trials
Trial Activity
Lipid Emulsion in Cardiac Valve Replacement Surgery
Unknown status·—·N/A·NCT04951791·68 enrolled
Short Term Effect of Vitamin D Supplementation on the Clinical Outcomes in Patients Undergoing Valve Replacement Surgery
Completed·—·Phase 4·NCT04085770·86 enrolled
Antiarrhythmic and Cardioprotective Effects of Atorvastatin Versus Magnesium Sulfate in Cardiac Valve Replacement Surgery
Unknown status·—·Phase 4·NCT03289429·96 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)